Healthcare & Life Sciences

Salvia BioElectronics

aliveseries-b
series-b
Stage
2017
Founded
2
Investors

About

Salvia BioElectronics develops a neuromodulation therapy for chronic migraine using ultra-thin implants to target key nerves, currently undergoing clinical evaluation.

Explore Salvia BioElectronics's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.